From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work
Open Access
- 29 July 2019
- journal article
- research article
- Published by Springer Nature in Drugs - Real World Outcomes
- Vol. 6 (3) , 125-132
Abstract
Randomised, double-blind, clinical trial methodology minimises bias in the measurement of treatment efficacy. However, most phase III trials in non-orphan diseases do not include individuals from the population to whom efficacy findings will be applied in the real world. Thus, a translation process must be used to infer effectiveness for these populations. Current conventional translation processes are not formalised and do not have a clear theoretical or practical base. There is a growing need for accurate translation, both for public health considerations and for supporting the shift towards personalised medicine.Keywords
This publication has 46 references indexed in Scilit:
- Effect Model Law: An Approach for the Implementation of Personalized MedicineJournal of Personalized Medicine, 2013
- Generalizing Evidence From Randomized Clinical Trials to Target Populations: The ACTG 320 TrialAmerican Journal of Epidemiology, 2010
- Revisiting the relationship between baseline risk and risk under treatmentEmerging Themes in Epidemiology, 2009
- Exaggeration of treatment benefits using the "event-based" number needed to treatCanadian Medical Association Journal, 2008
- Efficacy of acebutolol after acute myocardial infarction (the APSI trial)The American Journal of Cardiology, 1990
- Secondary prevention after high-risk acute myocardial infarction with low-dose acebutololThe American Journal of Cardiology, 1990
- Mechanism of relief of pacing induced angina with oral verapamil: reduced oxygen demand.Circulation, 1983
- One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.BMJ, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Explanatory and pragmatic attitudes in therapeutical trialsJournal of Chronic Diseases, 1967